Precision oncology is reshaping cancer care in India, driven by cheaper sequencing, AI‑powered mutation discovery, and pharma ...

Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia June 29, 2026 2:00 PM ...

CMS launches Medicare GLP-1 Bridge to offer select beneficiaries fixed-cost access to GLP-1 drugs from July 2026 through 2027.

Closing the rare disease diagnostic gap can improve patient care and outcomes. Did you know that one in 10 Americans have a ...

On June 30th, Skyhawk Therapeutics shared a press release with new twelve-month data from the ongoing Phase 1/2 trial of ...